Eileen McDermott

The U.S. Court of Appeals for the Federal Circuit (CAFC), in a precedential decision, on Thursday affirmed a district court ruling that found certain claims of Wyeth LLC’s two patents for methods of cancer treatment invalid for lack of enablement. Wyeth sued AstraZeneca Pharmaceuticals in September 2021, alleging that AstraZeneca induced infringement of its U.S. Patents 10,603,314 and 10,596,162 “based on marketing, distribution, and sales of its irreversible EGFR inhibitor Tagrisso (osimertinib).”

The U.S. Court of Appeals for the Federal Circuit (CAFC) today denied a request for mandamus relief by Lambeth Magnetic Structures, LLC, who asked the CAFC to direct the  U.S. District Court for the Western District of Pennsylvania to vacate its order staying a patent infringement suit pending resolution of an ex parte reexamination (EPR) of the asserted patent claims.

The United States government, on behalf of President Donald Trump, abandoned its application to register the trademark BOARD OF PEACE on July 3, after filing an express abandonment, according to U.S. Patent and Trademark Office (USPTO) documents. The application was a source of controversy earlier this year, when Representative Jamie Raskin (D-MD), Ranking Member of the House Judiciary Committee, sent a letter to USPTO Director John Squires pressing him to answer questions about the Office’s role in filing the trademark application on behalf of the Trump Administration.

The House Judiciary Committee’s Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet held a hearing on Tuesday, titled “A Midlife Crisis? IP and the Internet After 40.” The hearing examined the changes that have occurred over the last four decades of the internet and featured witnesses including celebrities, academics and computer and media experts.

The U.S. Court of Appeals for the Federal Circuit (CAFC), in a Per Curiam opinion, today affirmed a Trademark Trial and Appeal Board (TTAB) ruling that the mark MON AMI is confusingly similar to the previously registered mark, AMÌ, and that MON AMI could therefore not be registered.